Which of the following is a potential barrier to medication access due to the step therapy requirement?

• A. Immediate approval for prescribed medications
• B. Increased time to start effective treatment
• C. Unlimited access to all medications
• D. Longer consultation times

Answer: (B)

The potential barrier to medication access arising from a step therapy requirement is indeed the increased time to start effective treatment. Step therapy, also known as "fail first," requires patients to try and fail on one or more alternative treatments before the insurance will cover the prescribed medication. This process can lead to delays in receiving the most appropriate medication for a patient's condition, thereby prolonging the time before effective treatment can begin.

While immediate approval for prescribed medications and unlimited access to all medications would facilitate access to necessary treatments, step therapy inherently creates barriers by mandating specific prior treatments, delaying the process. Longer consultation times can be a factor in healthcare decisions, but the primary concern regarding step therapy is direct impact on the timeline for starting effective medications. Therefore, the delays introduced by the step therapy process are significant barriers in patient care and effective treatment initiation.